Published in Cancer Res on October 02, 2014
Long Noncoding RNAs in Cancer Pathways. Cancer Cell (2016) 1.63
Up-regulation of long noncoding RNA MALAT1 contributes to proliferation and metastasis in esophageal squamous cell carcinoma. J Exp Clin Cancer Res (2015) 1.36
Long non-coding RNA TUG1 is up-regulated in hepatocellular carcinoma and promotes cell growth and apoptosis by epigenetically silencing of KLF2. Mol Cancer (2015) 1.17
NEAT expression is associated with tumor recurrence and unfavorable prognosis in colorectal cancer. Oncotarget (2015) 1.13
Long noncoding RNAs in cancer: from function to translation. Trends Cancer (2015) 1.06
Increased expression of long noncoding RNA TUG1 predicts a poor prognosis of gastric cancer and regulates cell proliferation by epigenetically silencing of p57. Cell Death Dis (2016) 1.06
Long noncoding RNA HOXA-AS2 promotes gastric cancer proliferation by epigenetically silencing P21/PLK3/DDIT3 expression. Oncotarget (2015) 1.05
Molecular mechanisms of long noncoding RNAs on gastric cancer. Oncotarget (2016) 1.04
Recent advances in the molecular diagnostics of gastric cancer. World J Gastroenterol (2015) 1.01
Decreased long noncoding RNA SPRY4-IT1 contributing to gastric cancer cell metastasis partly via affecting epithelial-mesenchymal transition. J Transl Med (2015) 0.99
Long non-coding RNA HULC as a novel serum biomarker for diagnosis and prognosis prediction of gastric cancer. Oncotarget (2016) 0.95
Gastric cancer and gene copy number variation: emerging cancer drivers for targeted therapy. Oncogene (2015) 0.94
Long non-coding RNA Loc554202 induces apoptosis in colorectal cancer cells via the caspase cleavage cascades. J Exp Clin Cancer Res (2015) 0.93
Long non-coding RNAs in gastric cancer: versatile mechanisms and potential for clinical translation. Am J Cancer Res (2015) 0.92
Roles, Functions, and Mechanisms of Long Non-coding RNAs in Cancer. Genomics Proteomics Bioinformatics (2016) 0.91
Somatic gene copy number alterations in colorectal cancer: new quest for cancer drivers and biomarkers. Oncogene (2015) 0.89
Long noncoding RNA GAPLINC promotes invasion in colorectal cancer by targeting SNAI2 through binding with PSF and NONO. Oncotarget (2016) 0.86
E2F1-induced upregulation of long noncoding RNA LINC00668 predicts a poor prognosis of gastric cancer and promotes cell proliferation through epigenetically silencing of CKIs. Oncotarget (2016) 0.85
Dysregulation of non-coding RNAs in gastric cancer. World J Gastroenterol (2015) 0.84
Long Non-Coding RNA ucoo2kmd.1 Regulates CD44-Dependent Cell Growth by Competing for miR-211-3p in Colorectal Cancer. PLoS One (2016) 0.83
Long noncoding RNAs in gastric cancer: functions and clinical applications. Onco Targets Ther (2016) 0.83
The long non-coding RNA EPB41L4A-AS2 inhibits tumor proliferation and is associated with favorable prognoses in breast cancer and other solid tumors. Oncotarget (2016) 0.83
Long Noncoding RNA in Digestive Tract Cancers: Function, Mechanism, and Potential Biomarker. Oncologist (2015) 0.82
Long non-coding RNAs: potential new biomarkers for predicting tumor invasion and metastasis. Mol Cancer (2016) 0.82
LncRNAs as new biomarkers to differentiate triple negative breast cancer from non-triple negative breast cancer. Oncotarget (2016) 0.81
A novel long noncoding RNA-LOWEG is low expressed in gastric cancer and acts as a tumor suppressor by inhibiting cell invasion. J Cancer Res Clin Oncol (2015) 0.81
Increased expression of long-noncoding RNA ZFAS1 is associated with epithelial-mesenchymal transition of gastric cancer. Aging (Albany NY) (2016) 0.81
Functions and mechanisms of long noncoding RNAs in lung cancer. Onco Targets Ther (2016) 0.79
Long non-coding RNA LINC00628 functions as a gastric cancer suppressor via long-range modulating the expression of cell cycle related genes. Sci Rep (2016) 0.79
Gain-of-function miRNA signature by mutant p53 associates with poor cancer outcome. Oncotarget (2016) 0.79
HULC: an oncogenic long non-coding RNA in human cancer. J Cell Mol Med (2016) 0.79
Long Noncoding RNAs: At the Intersection of Cancer and Chromatin Biology. Cold Spring Harb Perspect Med (2017) 0.78
Expression and Function of CD44 in Epithelial Ovarian Carcinoma. Biomolecules (2015) 0.78
Long noncoding RNA expression profiles in gut tissues constitute molecular signatures that reflect the types of microbes. Sci Rep (2015) 0.78
Cancer subtypes classification using long non-coding RNA. Oncotarget (2016) 0.78
LncRNAs and cancer. Oncol Lett (2016) 0.77
A Tumor-Specific Prognostic Long Non-Coding RNA Signature in Gastric Cancer. Med Sci Monit (2016) 0.77
Emerging roles of non-coding RNAs in gastric cancer: Pathogenesis and clinical implications. World J Gastroenterol (2016) 0.77
The Emerging Function and Mechanism of ceRNAs in Cancer. Trends Genet (2016) 0.77
Long non-coding RNA linc00261 suppresses gastric cancer progression via promoting Slug degradation. J Cell Mol Med (2016) 0.76
Long noncoding RNA ANRIL could be transactivated by c-Myc and promote tumor progression of non-small-cell lung cancer. Onco Targets Ther (2016) 0.76
Twist2 promotes kidney cancer cell proliferation and invasion by regulating ITGA6 and CD44 expression in the ECM-receptor interaction pathway. Onco Targets Ther (2016) 0.76
Identification of a long non-coding RNA NR_026689 associated with lung carcinogenesis induced by NNK. Oncotarget (2016) 0.76
Long noncoding RNA RP11-838N2.4 enhances the cytotoxic effects of temozolomide by inhibiting the functions of miR-10a in glioblastoma cell lines. Oncotarget (2016) 0.76
DC - SIGNR by influencing the lncRNA HNRNPKP2 upregulates the expression of CXCR4 in gastric cancer liver metastasis. Mol Cancer (2017) 0.76
Long Noncoding RNA CCAT2 as a Potential Novel Biomarker to Predict the Clinical Outcome of Cancer Patients: A Meta-Analysis. J Cancer (2017) 0.76
Genomic-Wide Analysis with Microarrays in Human Oncology. Microarrays (Basel) (2015) 0.75
A unified model of the hierarchical and stochastic theories of gastric cancer. Br J Cancer (2017) 0.75
Co-expressed differentially expressed genes and long non-coding RNAs involved in the celecoxib treatment of gastric cancer: An RNA sequencing analysis. Exp Ther Med (2016) 0.75
Hypoxia Promotes Gastric Cancer Malignancy Partly through the HIF-1α Dependent Transcriptional Activation of the Long Non-coding RNA GAPLINC. Front Physiol (2016) 0.75
LincRNAFEZF1-AS1 represses p21 expression to promote gastric cancer proliferation through LSD1-Mediated H3K4me2 demethylation. Mol Cancer (2017) 0.75
Long noncoding RNA HOXA-AS2 represses P21 and KLF2 expression transcription by binding with EZH2, LSD1 in colorectal cancer. Oncogenesis (2017) 0.75
Metastasis-associated long noncoding RNAs in gastrointestinal cancer: Implications for novel biomarkers and therapeutic targets. World J Gastroenterol (2016) 0.75
Hypoxia/lncRNA-AK123072/EGFR pathway induced metastasis and invasion in gastric cancer. Int J Clin Exp Med (2015) 0.75
LncRNAs: From Basic Research to Medical Application. Int J Biol Sci (2017) 0.75
Active Components of Fungus Shiraia bambusiscola Can Specifically Induce BGC823 Gastric Cancer Cell Apoptosis. Cell J (2016) 0.75
Integrated analysis of long non-coding RNAs in human gastric cancer: An in silico study. PLoS One (2017) 0.75
Long non-coding RNA and tumor hypoxia: new players ushered toward an old arena. J Biomed Sci (2017) 0.75
The long noncoding RNA lnc-EGFR stimulates T-regulatory cells differentiation thus promoting hepatocellular carcinoma immune evasion. Nat Commun (2017) 0.75
Prognostic value of microRNAs in gastric cancer: a meta-analysis. Oncotarget (2017) 0.75
Tumor-associated macrophages produce interleukin 6 and signal via STAT3 to promote expansion of human hepatocellular carcinoma stem cells. Gastroenterology (2014) 1.35
Inhibition of Fatty Acid Oxidation Modulates Immunosuppressive Functions of Myeloid-Derived Suppressor Cells and Enhances Cancer Therapies. Cancer Immunol Res (2015) 0.98
TMEFF2 deregulation contributes to gastric carcinogenesis and indicates poor survival outcome. Clin Cancer Res (2014) 0.84